Francisco Eduardo Martinez

Prof. Francisco Eduardo Martinez

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
BFBeatriz A Fioruci-Fontanelli
Beatriz A Fioruci-Fontanelli
LMLeonardo O Mendes
Leonardo O Mendes
FSFabio Seiva
Fabio Seiva
MMMarcelo Martinez
Marcelo Martinez
Francisco Eduardo MartinezFrancisco Eduardo Martinez
Francisco Eduardo Martinez
Background: Toll-like receptors (TLRs) are effector molecules expressed on the surface of ovarian cancer (OC) cells, but the functions of the TLR2/TLR4 signaling pathways in these cells remain unclear. Melatonin (mel) acts as an anti-inflammatory factor and has been reported to modulate TLRs in some aggressive tumor cell types. Therefore, we investigated OC and the effect of long-term mel therapy on the signaling pathways mediated by TLR2 and TLR4 via myeloid differentiation factor 88 (MyD88) and toll-like receptor-associated activator of interferon (TRIF) in an ethanol-preferring rat model. Methods: To induce OC, the left ovary of animals either consuming 10% (v/v) ethanol or not was injected directly under the bursa with a single dose of 100 μg of 7,12-dimethylbenz(a)anthracene (DMBA) dissolved in 10 μL of sesame oil. The right ovaries were used as sham-surgery controls. After developing OC, half of the animals received i.p. injections of mel (200 μg/100 g b.w./day) for 60 days. Results: Although mel therapy was unable to reduce TLR2 levels, it was able to suppress the OC-associated increase in the levels of the following proteins: TLR4, MyD88, nuclear factor kappa B (NFkB p65), inhibitor of NFkB alpha (IkBα), IkB kinase alpha (IKK-α), TNF receptor-associated factor 6 (TRAF6), TRIF, interferon regulatory factor 3 (IRF3), interferon β (IFN-β), tumor necrosis factor alpha (TNF-α), and interleukin (IL)-6. In addition, mel significantly attenuated the expression of IkBα, NFkB p65, TRIF and IRF-3, which are involved in TLR4-mediated signaling in OC during ethanol intake. Conclusion: Collectively, our results suggest that mel attenuates the TLR4-induced MyD88- and TRIF-dependent signaling pathways in ethanol-preferring rats with OC.

2 August 2011 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
FSFabio Seiva
Fabio Seiva
WFWagner José Fávaro
Wagner José Fávaro
Giovana Rampazzo TeixeiraGiovana Rampazzo Teixeira
Giovana Rampazzo Teixeira
JAJoão Pa Amorim
João Pa Amorim
Francisco Eduardo MartinezFrancisco Eduardo Martinez
Francisco Eduardo Martinez
Background: Melatonin is associated with direct or indirect actions upon female reproductive function. However, its effects on sex hormones and steroid receptors during ovulation are not clearly defined. This study aimed to verify whether exposure to long-term melatonin is able to cause reproductive hormonal disturbances as well as their role on sex steroid receptors in the rat ovary, oviduct and uterus during ovulation. Methods: Twenty-four adult Wistar rats, 60 days old (+/- 250 g) were randomly divided into two groups. Control group (Co): received 0.9% NaCl 0.3 mL + 95% ethanol 0.04 mL as vehicle; Melatonin-treated group (MEL): received vehicle + melatonin [100 μg/100 g BW/day] both intraperitoneally during 60 days. All animals were euthanized by decapitation during the morning estrus at 4 a.m. Results: Melatonin significantly reduced the plasma levels of LH and 17 beta-estradiol, while urinary 6-sulfatoximelatonin (STM) was increased at the morning estrus. In addition, melatonin promoted differential regulation of the estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR) and melatonin receptor (MTR) along the reproductive tissues. In ovary, melatonin induced a down-regulation of ER-alpha and PRB levels. Conversely, it was observed that PRA and MT1R were up-regulated. In oviduct, AR and ER-alpha levels were down-regulated, in contrast to high expression of both PRA and PRB. Finally, the ER-beta and PRB levels were down-regulated in uterus tissue and only MT1R was up-regulated. Conclusions: We suggest that melatonin partially suppress the hypothalamus-pituitary-ovarian axis, in addition, it induces differential regulation of sex steroid receptors in the ovary, oviduct and uterus during ovulation.

Verified
Journal Article
Open access
PDF file
YZYohan Ricci Zonta
Yohan Ricci Zonta
MMMarcelo Martinez
Marcelo Martinez
ICIsabel Cristina C. Camargo
Isabel Cristina C. Camargo
RDRaquel F. Domeniconi
Raquel F. Domeniconi
LJLuiz Antonio Lupi Júnior
Luiz Antonio Lupi Júnior
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
Angiogenesis is a hallmark of ovarian cancer (OC); the ingrowth of blood vessels promotes rapid cell growth and the associated metastasis. Melatonin is a well-characterized indoleamine that possesses important anti-angiogenic properties in a set of aggressive solid tumors. Herein, we evaluated the role of melatonin therapy on the angiogenic signaling pathway in OC of an ethanol-preferring rat model that mimics the same pathophysiological conditions occurring in women. OC was chemically induced with a single injection of 7,12-dimethylbenz(a)anthracene (DMBA) under the ovarian bursa. After the rats developed serous papillary OC, half of the animals received intraperitoneal injections of melatonin (200 µg/100 g body weight/day) for 60 days. Melatonin-treated animals showed a significant reduction in OC size and microvessel density. Serum levels of melatonin were higher following therapy, and the expression of its receptor MT1 was significantly increased in OC-bearing rats, regardless of ethanol intake. TGFβ1, a transforming growth factor-beta1, was reduced only after melatonin treatment. Importantly, vascular endothelial growth factor (VEGF) was severely reduced after melatonin therapy in animals given or not given ethanol. Conversely, the levels of VEGF receptor 1 (VEGFR1) was diminished after ethanol consumption, regardless of melatonin therapy, and VEGFR2 was only reduced following melatonin. Hypoxia-inducible factor (HIF)-1α was augmented with ethanol consumption, and, notably, melatonin significantly reduced their levels. Collectively, our results suggest that melatonin attenuates angiogenesis in OC in an animal model of ethanol consumption; this provides a possible complementary therapeutic opportunity for concurrent OC chemotherapy.

1 March 2011 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
JAJ.P.A. Amorim
J.P.A. Amorim
Giovana Rampazzo TeixeiraGiovana Rampazzo Teixeira
Giovana Rampazzo Teixeira
LML.O. Mendes
L.O. Mendes
BFB.A. Fioruci
B.A. Fioruci
Francisco Eduardo MartinezFrancisco Eduardo Martinez
Francisco Eduardo Martinez
Melatonin regulates the reproductive cycle, energy metabolism and may also act as a potential antioxidant indoleamine. The present study was undertaken to investigate whether long-term melatonin treatment can induce reproductive alterations and if it can protect ovarian tissue against lipid peroxidation during ovulation. Twenty-four adult female Wistar rats, 60 days old (+/- 250-260 g), were randomly divided into two equal groups. The control group received 0.3 mL 0.9% NaCl + 0.04 mL 95% ethanol as vehicle, and the melatonin-treated group received vehicle + melatonin (100 mu g.100 g body weight(-1).day(-1)) both intraperitoneally daily for 60 days. All animals were killed by decapitation during the morning estrus at 4: 00 am. Body weight gain and body mass index were reduced by melatonin after 10 days of treatment (P < 0.05). Also, a marked loss of appetite was observed with a fall in food intake, energy intake (melatonin 51.41 +/- 1.28 vs control 57.35 +/- 1.34 kcal/day) and glucose levels (melatonin 80.3 +/- 4.49 vs control 103.5 +/- 5.47 mg/dL) towards the end of treatment. Melatonin itself and changes in energy balance promoted reductions in ovarian mass (20.2%) and estrous cycle remained extensive (26.7%), arresting at diestrus. Regarding the oxidative profile, lipid hydroperoxide levels decreased after melatonin treatment (6.9%) and total antioxidant substances were enhanced within the ovaries (23.9%). Additionally, melatonin increased superoxide dismutase (21.3%), catalase (23.6%) and glutathione-reductase (14.8%) activities and the reducing power (10.2% GSH/GSSG ratio). We suggest that melatonin alters ovarian mass and estrous cyclicity and protects the ovaries by increasing superoxide dismutase, catalase and glutathione-reductase activities.

17 August 2014 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
SOSuelen A. Oliveira
Suelen A. Oliveira
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
BFBeatriz Aparecida Fioruci-Fontanelli
Beatriz Aparecida Fioruci-Fontanelli
FNFermino Sanches Lizarte Neto
Fermino Sanches Lizarte Neto
PNPaulo CEZAR Novais
Paulo CEZAR Novais
Francisco Eduardo MartinezFrancisco Eduardo Martinez
Francisco Eduardo Martinez

18 January 2011 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
LMLeonardo O. Mendes
Leonardo O. Mendes
JAJoão Paulo A. Amorim
João Paulo A. Amorim
Giovana Rampazzo TeixeiraGiovana Rampazzo Teixeira
Giovana Rampazzo Teixeira
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
BFBeatriz Aparecida Fioruci
Beatriz Aparecida Fioruci
Francisco Eduardo MartinezFrancisco Eduardo Martinez
Francisco Eduardo Martinez